Abstract

Recent advances in microRNAome have made microRNAs (miRNAs) a compelling novel class of biomarker in cancer biology. In the present study, the role of miR-23a in the carcinogenesis of colorectal cancer (CRC) was investigated. Cell viability, apoptosis, and caspase 3/7 activation analyses were conducted to determine the potentiality of apoptosis resistance function of miR-23a in CRC. Luciferase assay was performed to verify a putative target site of miR-23a in the 3'-UTR of apoptosis protease activating factor 1 (APAF1) mRNA. The expression levels of miR-23a and APAF1 in CRC cell lines (SW480 and SW620) and clinical samples were assessed using reverse transcription-quantitative real-time PCR (RT-qPCR) and Western blot. We found that the inhibition of miR-23a in SW480 and SW620 cell lines resulted in significant reduction of cell viability and promotion of cell apoptosis. Moreover, miR-23a up-regulation was coupled with APAF1 down-regulation in CRC tissue samples. Taken together, miR-23a was identified to regulate apoptosis in CRC. Our study highlights the potential application of miR-23a/APAF1 regulation axis in miRNA-based therapy and prognostication.

Highlights

  • Colorectal cancer (CRC) is the third most common cancer worldwide [1]

  • The clinical samples were categorized into less advanced tumor and more advanced tumor. miR-23a was significantly over-expressed in the blood and cancer tissues when compared to the control/normal counterparts

  • The Western blot analysis showed that the level of apoptosis protease activating factor 1 (APAF1) protein was significantly decreased by 0.51 ± 0.08-fold in SW480 and 0.46 ± 0.17-fold in SW620 following miR-23a mimic transfection and significantly increased by 1.76 ± 0.28-fold in

Read more

Summary

Introduction

Colorectal cancer (CRC) is the third most common cancer worldwide [1]. The carcinogenesis of CRC is heterogeneous, multi-factorial, and may take several decades. MiRNA deregulation in apoptosis contributes to CRC development and resistance to anti-cancer therapy. Over-expression of miR-92a has been reported to cause uncontrollable cell proliferation in CRC via the down-regulation of pro-apoptotic molecule. Programmed cell death 4 (PDCD4), a tumor suppressor protein that is often down-regulated in CRC, is caused by the up-regulation of miR-21 [9,10]. Chang et al has revealed the significance of miR-34a in regulating p53 network of cell cycle control and apoptosis in CRC [11]. Through miRNA microarray study, we had demonstrated that miR-23a may serve as a potential biomarker for the detection of CRC [12]. The focus of this study is to investigate the potentiality of apoptosis resistance function of miR-23a in CRC

Results
Modulation of APAF1 Expression in SW480 and SW620 Cell Lines
APAF1 Down-Regulation in Clinical CRC Samples
Discussion
Clinical Sample Collection and Preservation
Cell Culture
Total RNA Extraction
Total Protein Extraction and Western Blot
Luciferase Reporter Construct
Luciferase Assay
3.10. Cell Viability Assay
3.11. Apoptosis Assay and Image-Based Cytometry
3.13. Statistical Analysis
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call